Amalgamated Bank Nevro Corp Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Nevro Corp stock. As of the latest transaction made, Amalgamated Bank holds 1,272 shares of NVRO stock, worth $5,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,272

Previous 1,272 -0.0%

Holding current value

$5,749

Previous $11,000 36.36%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$13.56 - $20.78 $34,713 - $53,196	-2,560 Reduced 66.81%	1,272 $18,000
Q4 2023 Feb 06, 2024	SELL	$14.18 - $22.31 $5,360 - $8,433	-378 Reduced 8.98%	3,832 $82,000
Q2 2023 Aug 11, 2023	SELL	$22.62 - $39.32 $16,670 - $28,978	-737 Reduced 14.9%	4,210 $107,000
Q1 2023 May 02, 2023	SELL	$30.17 - $41.11 $19,218 - $26,187	-637 Reduced 11.41%	4,947 $179,000
Q3 2022 Nov 09, 2022	BUY	$40.66 - $53.03 $3,537 - $4,613	87 Added 1.58%	5,584 $260,000
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $6,862 - $13,048	-168 Reduced 2.97%	5,497 $241,000
Q1 2022 Jun 30, 2022	SELL	$59.95 - $92.06 $25,478 - $39,125	-425 Reduced 6.98%	5,665 $410,000
Q4 2021 Feb 15, 2022	SELL	$81.07 - $121.29 $5,269 - $7,883	-65 Reduced 1.06%	6,090 $494,000
Q3 2021 Oct 29, 2021	SELL	$101.99 - $166.36 $38,654 - $63,050	-379 Reduced 5.8%	6,155 $716,000
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $239,728 - $303,148	1,693 Added 34.97%	6,534 $1.08 Million
Q1 2021 May 13, 2021	SELL	$132.81 - $182.18 $62,819 - $86,171	-473 Reduced 8.9%	4,841 $675,000
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $12,711 - $16,959	92 Added 1.76%	5,314 $919,000
Q3 2020 Oct 30, 2020	SELL	$114.09 - $145.51 $17,455 - $22,263	-153 Reduced 2.85%	5,222 $727,000
Q2 2020 Aug 10, 2020	BUY	$89.45 - $129.85 $6,261 - $9,089	70 Added 1.32%	5,375 $642,000
Q1 2020 May 13, 2020	SELL	$70.23 - $144.31 $11,096 - $22,800	-158 Reduced 2.89%	5,305 $530,000
Q4 2019 Feb 13, 2020	BUY	$76.41 - $117.54 $18,414 - $28,327	241 Added 4.62%	5,463 $642,000
Q3 2019 Nov 13, 2019	SELL	$61.52 - $91.1 $4,490 - $6,650	-73 Reduced 1.38%	5,222 $449,000
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $52,061 - $60,090	897 Added 20.4%	5,295 $343,000
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $156,216 - $275,402	4,398 New	4,398 $275,000
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $196,248 - $334,935	-4,438 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$72.38 - $92.5 $50,304 - $64,287	695 Added 18.57%	4,438 $354,000
Q1 2018 May 22, 2018	SELL	$69.46 - $88.57 $1,111 - $1,417	-16 Reduced 0.43%	3,743 $324,000
Q4 2017 Feb 13, 2018	BUY	$65.94 - $93.31 $15,034 - $21,274	228 Added 6.46%	3,759 $260,000
Q3 2017 Nov 09, 2017	BUY	$80.87 - $91.08 $285,551 - $321,603	3,531	3,531 $321,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Nevro Corp Transaction History